IRVINE, Calif., April 15 /PRNewswire-FirstCall/ -- Endologix,
Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for
aortic disorders, announced today details relating to the release
of its first quarter 2010 financial results, which will take place
on Thursday, April 22, 2010 after the
close of the market.
Endologix will hold a conference call on Thursday, April 22, 2010 at 5:00 p.m. ET / 2:00 p.m.
PT to discuss the results. The dial-in numbers are (877)
407-0789 for domestic callers and (201) 689-8562 for international
callers. A live Web cast of the conference call will be available
online from the investor relations page of the Company's corporate
website at www.endologix.com.
After the live Web cast, the call will remain available on
Endologix's Web site, www.endologix.com, through May 22, 2010. In addition, a telephonic replay of
the call will be available until April 29,
2010. The replay dial-in numbers are (877) 660-6853 for
domestic callers and (201) 612-7415 for international callers.
Please use account number 3055 and conference ID number
348731.
About Endologix
Endologix, Inc. develops and manufactures minimally invasive
treatments for aortic disorders. The Company's flagship product is
the Powerlink® System, which is an endovascular stent graft for the
treatment of abdominal aortic aneurysms (AAA). AAA is a weakening
of the wall of the aorta, the largest artery in the body, resulting
in a balloon-like enlargement. Once AAA develops, it continues to
enlarge and, if left untreated, becomes increasingly susceptible to
rupture. The overall patient mortality rate for ruptured AAA is
approximately 75%, making it a leading cause of death in the U.S.
Additional information can be found on Endologix's Web site at
www.endologix.com.
COMPANY
CONTACT:
|
INVESTOR
CONTACTS:
|
|
Endologix, Inc.
|
The Ruth
Group
|
|
John McDermott, CEO
|
Nick Laudico (646)
536-7030
|
|
(949) 595-7200
|
Zack Kubow (646) 536-7020
|
|
www.endologix.com
|
|
|
|
|
SOURCE Endologix, Inc.